Recent Advances in Studies of Skin Color and Skin Cancer.

cytidine as melanin inhibitor leucocyte-tumor cell hybrids melanin transfer skin cancer skin color

Journal

The Yale journal of biology and medicine
ISSN: 1551-4056
Titre abrégé: Yale J Biol Med
Pays: United States
ID NLM: 0417414

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 1 4 2020
pubmed: 1 4 2020
medline: 24 4 2021
Statut: epublish

Résumé

The relationship between skin color and skin cancer is well established: the less melanin in one's skin the greater the risk for developing skin cancer. This review is in two parts. First, we summarize the current understanding of the cutaneous pigmentary system and trace melanin from its synthesis in the pigment cell melanosomes through its transfer to keratinocytes. We also present new methods for reducing melanin content in hyper-pigmented areas of skin such as solar lentigenes, melasma, and post-inflammatory hyperpigmentation. Second, we present evidence that at least one mechanism for the development of metastatic melanoma and other solid tumors is fusion and hybridization of leucocytes such as macrophages with primary tumor cells. In this scenario, hybrid cells express both the chemotactic motility of the leucocyte and the de-regulated cell division of the tumor cell, causing the cells to migrate a deadly journey to lymph nodes, distant organs, and tissues.

Identifiants

pubmed: 32226338
pmc: PMC7087065

Substances chimiques

Melanins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-80

Informations de copyright

Copyright ©2020, Yale Journal of Biology and Medicine.

Références

Exp Dermatol. 2014 Nov;23(11):813-8
pubmed: 25180917
Cells. 2019 Feb 18;8(2):
pubmed: 30781683
Arch Dermatol Res. 2019 Apr;311(3):249-250
pubmed: 30788567
PLoS One. 2013 Jun 26;8(6):e66731
pubmed: 23840523
Int J Cancer. 2009 Oct 15;125(8):1826-31
pubmed: 19582880
Cell Mol Life Sci. 2015 Oct;72(19):3769-82
pubmed: 25900663
J Theor Biol. 1993 Sep 7;164(1):103-20
pubmed: 8264240
Exp Cell Res. 2007 Nov 1;313(18):3840-50
pubmed: 17850789
J Invest Dermatol. 2008 Jan;128(1):151-61
pubmed: 17671519
Melanoma Res. 2009 Dec;19(6):343-9
pubmed: 22760065
Exp Dermatol. 2003;12 Suppl 2:5-12
pubmed: 14756517
Glycoconj J. 2015 Aug;32(6):413-20
pubmed: 26194059
Physiol Rev. 2004 Oct;84(4):1155-228
pubmed: 15383650
Physiol Rev. 2000 Jul;80(3):979-1020
pubmed: 10893429
Int J Mol Sci. 2016 Jul 13;17(7):
pubmed: 27420051
J Invest Dermatol. 2012 Apr;132(4):1073-4
pubmed: 22418942
Arch Biochem Biophys. 2014 Dec 1;563:79-93
pubmed: 24997364
Endocr Rev. 2013 Dec;34(6):827-84
pubmed: 23939821
Cell Mol Biol (Noisy-le-grand). 1999 Nov;45(7):1011-27
pubmed: 10644005
J Cosmet Dermatol. 2019 Feb;18(1):278-285
pubmed: 30291682
Nat Rev Cancer. 2008 May;8(5):377-86
pubmed: 18385683
Cancer Microenviron. 2014 Aug;7(1-2):61-9
pubmed: 24771466
BMC Cancer. 2015 Nov 20;15:922
pubmed: 26585897
Crit Rev Oncog. 2013;18(1-2):97-113
pubmed: 23237554
Lancet Oncol. 2005 Dec;6(12):988-93
pubmed: 16321767
J Cutan Pathol. 2010 Feb;37(2):256-68
pubmed: 19615007
Cell Adh Migr. 2007 Jan-Mar;1(1):2-6
pubmed: 19262091
Urol Oncol. 2018 Apr;36(4):159.e19-159.e26
pubmed: 29288002
J Eur Acad Dermatol Venereol. 2011 Dec;25(12):1369-80
pubmed: 22077870
Exp Dermatol. 2015 Apr;24(4):258-9
pubmed: 25496715
Cell Growth Differ. 1999 Jul;10(7):517-24
pubmed: 10437919
J Cell Sci. 2012 Sep 15;125(Pt 18):4306-19
pubmed: 22641693
Int J Cancer. 2008 Aug 15;123(4):780-6
pubmed: 18506688
Sci Adv. 2018 Sep 12;4(9):eaat7828
pubmed: 30214939
Photochem Photobiol. 2008 May-Jun;84(3):539-49
pubmed: 18435612
PLoS One. 2017 Feb 1;12(2):e0168581
pubmed: 28146572
J Cancer Res Clin Oncol. 2018 Jul;144(7):1253-1263
pubmed: 29725763
Oncotarget. 2017 Dec 27;9(5):6156-6173
pubmed: 29464062
Endocrinology. 2018 May 1;159(5):1992-2007
pubmed: 29546369
J Invest Dermatol. 2003 Sep;121(3):529-41
pubmed: 12925212
Cell Growth Differ. 2001 Dec;12(12):623-30
pubmed: 11751457
Int J Mol Sci. 2016 Jun 02;17(6):
pubmed: 27271591
Curr Opin Cell Biol. 2014 Aug;29:1-7
pubmed: 24662021
J Invest Dermatol. 2000 Aug;115(2):162-7
pubmed: 10951231

Auteurs

Greggory S LaBerge (GS)

Human Medical Genetics and Genomics Program, University of Colorado School of Medicine, Denver, CO.
Denver Police Crime Lab-Forensics and Evidence Division, Denver, CO.

Eric Duvall (E)

Denver Police Crime Lab-Forensics and Evidence Division, Denver, CO.

Zachary Grasmick (Z)

Department of Pathology, University of Colorado AMC, Denver, CO.

Kay Haedicke (K)

Department of Internal Medicine Section of Medical Oncology and the Yale Cancer Center, Yale School of Medicine, New Haven, CT.

Anjela Galan (A)

Department of Dermatology and The Yale Cancer Center, Yale School of Medicine, New Haven, CT.

Jesse Leverett (J)

The Amway Corporation, Ada, MI.

Sudhir Baswan (S)

The Amway Corporation, Ada, MI.

Sunghan Yim (S)

The Amway Corporation, Ada, MI.

John Pawelek (J)

Department of Dermatology and The Yale Cancer Center, Yale School of Medicine, New Haven, CT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH